|
ZC3H11A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.04520000052422E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69968999998993E-05 |
| Normal-vs-Stage2 |
1.73712999999021E-05 |
| Normal-vs-Stage3 |
1.28820000000474E-06 |
| Normal-vs-Stage4 |
1.59824999999003E-05 |
| Stage1-vs-Stage2 |
3.314600E-01 |
| Stage1-vs-Stage3 |
2.509600E-01 |
| Stage1-vs-Stage4 |
4.219400E-01 |
| Stage2-vs-Stage3 |
9.186400E-01 |
| Stage2-vs-Stage4 |
8.690200E-01 |
| Stage3-vs-Stage4 |
9.390000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.71310000208447E-08 |
| Normal-vs-AfricanAmerican |
1.611990E-01 |
| Normal-vs-Asian |
2.119700E-03 |
| Caucasian-vs-AfricanAmerican |
2.408100E-02 |
| Caucasian-vs-Asian |
2.154200E-01 |
| AfricanAmerican-vs-Asian |
2.490200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.1046000000009E-05 |
| Normal-vs-Female |
2.43869999971835E-07 |
| Male-vs-Female |
4.088000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.80065999999535E-05 |
| Normal-vs-Age(41-60Yrs) |
1.5318999999625E-06 |
| Normal-vs-Age(61-80Yrs) |
4.05690000004899E-06 |
| Normal-vs-Age(81-100Yrs) |
5.194100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.889000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.052200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.871400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.379800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.335400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.070200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.624400E-03 |
| Classical-VS-Follicular |
3.622400E-02 |
| Classical-VS-Other |
6.080000E-01 |
| Classical-VS-Normal |
6.46690000000172E-05 |
| Tall-VS-Follicular |
3.064000E-01 |
| Tall-VS-Other |
3.927000E-01 |
| Tall-VS-Normal |
4.77319999969694E-07 |
| Follicular-VS-Other |
8.092600E-01 |
| Follicular-VS-Normal |
4.51120000000138E-06 |
| Other-VS-Normal |
3.927500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.14090000067091E-08 |
| Normal-vs-N1 |
1.29360000000744E-06 |
| N0-vs-N1 |
5.807200E-01 |
|
|
